ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation

Kuang, Qiwen; Liang, Yuxiang; Zhuo, Yangjia; Cai, Zhiduan; Jiang, Funeng; Xie, Jianjiang; Zheng, Yu; Zhong, Weide*广州医学院; 南方医科大学; 1; 5
OncoTargets and Therapy2021DOI: 10.2147/OTT.S290284
8被引3阅读
引用收藏
分享

摘要

Background: ALDOA plays an essential role in cancer progression in different human cancers; however, its function has not been understood in prostate cancer (PCa). @@@ Methods: Associations of ALDOA expression with clinicopathological features and patient prognosis in PCa were evaluated based on data obtained from the Taylor database and our clinical tissue microarray. The potential roles of ALDOA in malignant progression were verified using a series of in vivo and in vitro experiments after stable ALDOA overexpression and knockdown in DU145 and PC3 cell lines. An aldolase A inhibitor was used to determine the effects of inhibition of ALDOA on PCa cell proliferation. @@@ Results: Higher expression of ALDOA was positively correlated with the incidence of postoperative metastasis and biochemical recurrence (BCR) and may predict poor prognosis in PCa patients. In vivo experiments demonstrated that overexpression of ALDOA could significantly promote cell proliferation, prolong the cell cycle, and significantly reduce the apoptosis rate of PCa cells. Knockdown of expression of ALDOA could inhibit the proliferation and shorten the cell cycle of PCa cells significantly, with no significant effects on cell apoptosis (P > 0.05). In vitro experiments showed that overexpression of ALDOA could significantly promote tumor growth (P < 0.05), while treatment with the Aldolase A inhibitor naphthol AS-E phosphate dose-dependently suppressed the growth of PCa cells (P < 0.01). The analysis of datasets from the Taylor database showed that there was negative regulatory relationship between the expression of ALDOA and MYPT1 (P < 0.001). @@@ Conclusion: Our study revealed that ALDOA played an important role in the progression of PCa. The MYPT1-ALDOA signaling axis may be a new target for the clinical treatment of PCa patients given its negative regulatory relationship. Our study suggests that Aldolase A inhibitors may represent a novel approach to inhibit the growth of PCa.

学科与关键词

关键词
prostate cancerALDOAaldolase Atumor growthmetastasis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
OncoTargets and Therapy
发表日期
2021
卷期
第 14 卷
页码
3353-3366
DOI
10.2147/OTT.S290284
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072813, 81571427]; Natural Science Foundation of Guangdong Province [2018A030313668, 2020A1515110640]; Fundamental Research Funds for Central Universities [2018MS18]; Science Foundation of Guangzhou First People's Hospital [M2019016, Q2019020]; Science and Technology Fund of Guizhou Provincial Health Commision [gzwjkj2018-1-094, gzwjkj2019-1-133]

作者

  • K

    Kuang, Qiwen (第一作者)

    southern med univ

  • L

    Liang, Yuxiang

    1

查看全部 8 位作者收起作者
  • Z

    Zhuo, Yangjia

    1

  • C

    Cai, Zhiduan

    5 · guangzhou med univ

  • J

    Jiang, Funeng

    1

  • X

    Xie, Jianjiang

    1

  • Z

    Zheng, Yu

    2 · guangzhou med univ

  • Z

    Zhong, Weide (通讯)

    peoples hosp guizhou prov · 1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417